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Suml'nary 
The thymus leukemia (TL) antigen is a major histocompatibility  complex-encoded nonclassical 
class I molecule. Here we present data demonstrating that expression of the TL antigen, unlike 
other class I molecules, is completely independent of the function of the transporter associated 
with antigen processing (TAP). The TL antigen is expressed  by transfected TAP-2-deficient  RMA-S 
cells when these cells are grown at 37~  In transfected RMA cells, the kinetics of arrival of 
TL antigen on the cell surface are similar to those of a classical class I molecule. The kinetics 
are not altered in TAP-deficient RMA-S cells, demonstrating that surface TL expression in TAP- 
deficient cells is not due to the stable expression of a few molecules that leak out by a TAP- 
independent pathway. Soluble TL molecules produced by Drosophila raelanogaster cells are highly 
resistant to thermal denaturation, unlike peptide-free classical class I molecules synthesized by 
these insect cells. In addition,  these soluble TL molecules are devoid of detectable bound pep- 
tides. The results demonstrate that the TL antigen is capable of reaching the surface without 
bound peptide, although acquisition of peptide or some other ligand through a TAP-independent 
pathway cannot be formally excluded. We speculate that the ability of the TL antigen to reach 
the cell surface, under conditions  in which other class I molecules do not, may be related to 
a specialized function of the TL molecule in the mucosal immune system, and possibly in the 
stimulation of intestinal  ~  T  cells. 
G 
enes located in the MHC encode molecules that are 
involved in antigen presentation to T lymphocytes (for 
reviews see references 1, 2). Classical class I, or class Ia, H 
chains are encoded in the 1-1-2 K  and D subregions. They be- 
come noncovalently  associated with  a  12-kD  non-MHC- 
encoded protein,  fi2-microglobulin (32m)  1, in the endoplas- 
mic reticulum (ER) before their transport to the cell surface 
(3). Class I molecules present endogenously derived antigenic 
peptides of eight to nine amino acids to cytotoxic T lympho- 
cytes (4-6). A transporter associated with antigen processing 
(TAP) is encoded by two genes in the MHC called TAP-1 
and TAP-2. TAP-1 and TAP-2 proteins are required for trans- 
port of cytosolic peptides into the EK for binding to dassical 
class I molecules (7-10).  In general, both B2m and peptide 
1  Abbreviations used in this paper: /32m, /32-microglobulin; Endo H, en- 
doglycosidase  H; ER, endoplasmic  reticulum; TAP, transporter associated 
with antigen processing; TL, thymus leukemia. 
are required for classical class I molecules to be expressed on 
the cell surface. 
Nonclassical class I molecules, or class Ib molecules, are 
similar to the classical  class I molecules in terms of their amino 
acid sequence, and most require fl2m for cell surface expres- 
sion (11-13). In the mouse, the majority of these molecules 
are encoded in the Q,  T, and M subregions of the MHC; 
some are encoded outside of the MHC (12-16). With a few 
exceptions, the function of these molecules remains unknown, 
although a role for these molecules in antigen presentation 
is most likely (for review see reference 14). Several examples 
of class Ib presentation  of specific antigens  to T  cells have 
been documented (14, 17-20). In addition,  nonameric pep- 
tides have been eluted and sequenced from at least one class 
Ib molecule, Qa-2 (21, 22). 
The mouse thymus leukemia (TL) antigen is a class Ib mol- 
ecule encoded in the T region of the MHC (for review see 
reference 23). In all strains of mice, it is expressed only by 
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bred strains,  however, it is expressed by additional cell types, 
including  thymocytes (24-26).  The TL antigen is  >50% 
similar in sequence to K  and D  molecules for the or1 and 
c~2 domains. Conserved amino acids in the peptide-binding 
groove of classical class I molecules that make contact with 
bound peptide also are present in the TL antigen, suggesting 
that TL antigen may bind nonameric peptides (23). Although 
peptide specific, TL antigen-restricted T cdls have not been 
reported, allorecognition of TL antigen by CTL has recently 
been demonstrated, providing further evidence that this mol- 
ecule may function similarly to classical dass I molecules (27). 
Here we show that expression of the TL antigen is unique 
among MHC-encoded class I molecules in that it is expressed 
completely independently of  TAP function. By kinetic criteria, 
the TL antigen appears to traffic via an intraceUular pathway 
similar to the K and D molecules. We also provide evidence 
suggesting that TL antigen is thermostable at physiological 
temperatures in the absence ofpeptide, implying that it does 
not require the binding of specific peptides for its transport 
to and stable expression at the cell membrane. 
Materials and Methods 
Cell Lines.  The RMA-S and RMA cell lines were obtained from 
Dr. Linda Sherman (Scripps Research Institute, La  Jolla, CA). They 
were maintained in 5% CO2 at 37~  in KPMI medium (Gibco 
Laboratories, Grand Island, NY) supplemented with 5% fetal bo- 
vine serum (JRH Laboratories, Lenexa, KS), 2 mM L-glutamine, 
50 U/ml penicillin, 50 U/ml streptomycin, 5  x  10 -s M 2-ME, 
100 #g/ml nonessential amino acids, and 100 #g/ml sodium pyru- 
vate unless otherwise indicated. Culture of Drosophila melanogaster 
embryonic SC cells was carried out in Schneider medium (Gibco 
Laboratories) supplemented with 7% FCS at 27~  For the large- 
scale production of soluble TL antigen,/~ melanogaster cells were 
grown in serum-free insect medium (Insect Xpress; Whittaker Bi- 
oproducts, Walkersville, MD) in a roller bottle apparatus at 27~ 
Gene Constructs and Transfectants.  A  T18  a cDNA clone was ob- 
tained from Dr. F.-W. Shen (Tampa Bay Research Institute,  St. 
Petersburg,  FL).  The  TL  antigen  expression  constructs, 
pDT18dhGH and pH~/Apff18  a, and the chimeric molecule Ld/TL 
expression construct pH~AprLT18  a, have been previously  described 
(28). pHBAprT18  d encodes a full-length T18  d cDNA, while pH~- 
AprLT18  a encodes a genomic sequence containing the L d o~1 and 
o~2 domains coupled to a 7"/8  d genomic sequence  encoding the c~3, 
transmembrane, and cytoplasmic  domains. Both expression  plasmids 
are under the control of the human ~-actin promoter and contain 
the gene for neomycin resistance (29). pDT18dhGH contains the 
full-length 7"18  a cDNA under the control of the H-2D  a promoter 
(30). The plasmid pLdneo, containing  the H-2L d promoter and 
genomic coding sequences colinear with pSV2neo, was a gift of 
Dr. Martha Zuniga (University of California at Santa Cruz, Santa 
Cruz, CA). For expression of soluble TL molecules in D  melano- 
gaster cells, the plasmid TL.s-pRM, which encodes  a truncated form 
of the T18  a cDNA containing the signal peptide and the cd-cr 
domains, was generated by PCP,. Oligonucleotides corresponding 
to the 5' end of the T18  d leader sequence (CAAGAATTCACC- 
ATGGGGATGGGGACACCAGTGCCT) and the 3' end of exon 
4 (TCATAGGTACCAGGATCCATCCCATCTCAGC~TGAGAGG- 
CTCAG) introduced restriction enzyme sites, which allowed the 
cloning of the truncated cDNA into the pRMHa-3 expression  vector 
(31). This vector has the/~ melanogaster metallothionein gene pro- 
moter 5  ~ to the inserted cDNA and a sequence of six histidine 
amino acids followed by a translational stop codon at the 3' end. 
32m-pRM was generated by cloning a mouse B2m cDNA clone 
(32) into the insect cell expression vector. 
Gene transfer of 30 #g of pH~AprLT18  d or pH~/AprT18  a into 
107 RMA  or RMA-S cells was accomplished by standard elec- 
troporation procedures (gene transfector  300; BTX Inc., San Diego, 
CA). Alternatively, 20 #g of pDT18ahGH was coelectroporated 
with 10 #g of pSV2neo (33) into 107 RMA-S cells. G418 (Gibco 
Laboratories) selection at  700 #g/ml (RMA-S) and 300 ~g/ml 
(RMA) active drug began 48 h after electroporation,  and stable 
transfectants were analyzed for expression of the gene product 3-4 
wk later. SC2 El mdanogaster tissue culture cells were cotransfected 
with 12 #g of TL.s-pRM, 12 #g of mouse B2m-pKM, and 1 #g 
of pUChsneo (34) by the calcium phosphate method and selected 
with 500 #g/ml of G418 for 2 mo. 
Antibodies.  Antibodies used for flow cytometric analysis were 
28-8-6S for detection  of Kb/D  b (35; a gift of Dr.  Kita Effros, 
Department of  Pathology, University of  California at Los Angeles, 
Los Angeles, CA), 30-5-7 for the detection of L a and the La/TL 
molecule (36; a gift of  Dr. Iwona Stroynowski, Southwestern Med- 
ical Center, Dallas, Texas), AF6-88.5.3 for detection of K  b (37; 
American Type Culture Collection, Kockville, MD), and HD168 
(38; a gift from Drs. Elisabeth Stockert and Lloyd Old, Memorial 
Sloan Kettering, New York), 18/20 (39; a gift of  Dr. Kirsten Fischer 
Lindahl, Southwestern Medical Center),  and M4 (40; a gift from 
Drs. S. Kimura and E. Boyse, Memorial Sloan Kettering) for the 
detection of the TL antigen. All of the antibodies are of the IgG2a 
isotype and were raised in mice, with the exception of HD168, 
which  is  a rat  IgG1 mAb.  PE-conjugated goat  anti-mouse  Ig 
(CALTAG Labs, South San Francisco, CA) and goat anti-rat Ig 
(CALTAG Labs) were used as secondary reagents. For biochemical 
analyses, 28-14-8S, a mouse IgG2a antibody, was used to detect 
the D b molecule (36; American Type Culture Collection). 
Flow Cytometry.  For the flow cytometric analyses, cells were 
cultured  at 37~  or at room temperature  overnight before the 
addition of saturating amounts of mAb. Temperature shift assays 
were performed by incubating cells overnight at room temperature 
and then at 37~  for 3-5 h. Where indicated, peptides were added 
to the transfectants before shifting the cells to 37~  Cells were 
incubated for 30 rain, washed three times in PBS, and incubated 
in PE-conjugated secondary antibodies. Labeled  cells were analyzed 
by use of a FACScan  |  (Becton Dickinson & Co., Mountain View, 
CA) at the UCLA Flow Cytometry Core Facility. Dead cells were 
excluded  by incubating the cells with 7-amino actinomycin-D (41; 
Calbiochem Corp.,  La Jolla,  CA) before analysis. 
Pulse-Chase Labeling.  Cells  were preincubated  in KPMI without 
methionine (Gibco Laboratories) supplemented with 5% dialyzed 
fetal bovine serum (Gibco Laboratories) for 1 h. They were then 
metabolically labeled with 500 #Ci [3SS]methionine  (Tran3SS-label; 
ICN, Irvine, CA) per 107 cells for 30 rain,  washed, and chased 
in KPMI containing two times the normal methionine concentra- 
tion. Cells were lysed in 1 ml PLB (1% Triton X-100, 0.5% deoxy- 
cholate, 0.1% SDS, 0.1 M NaC1, 0.01 M Na phosphate, 1 mM 
PMSF) on ice for 1 h and cellular debris removed by centrifuga- 
tion. For immunoprecipitation of the TL antigen, the lysates were 
incubated with HD168 for 2 h at 4~  with constant rotation. Pro- 
tein G-Sepharose  beads (Pharmacia Inc., Piscataway,  NJ) were added, 
and the mixture was rotated for an additional 2 h at 4~  Beads 
were collected, washed three times in KLB (150 mM NaC1, 10 
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EDTA, 1 mM PMSF, 50/~g/ml leupeptin,  25/zg/ml aprotinin), 
and once in wash buffer 2 (0.15 M NaC1, 0.05 M Tris-HC1 [pH 
7.5], 5 mM EDTA, 1 mM PMSF). The immunoprecipitated pro- 
tein samples were dissolved by boiling the Sepharose beads in 60 
/~1 of dution buffer (0.02% SDS, 0.01 M "Iris HC1 [pH 7.5], 0.1 
M Na citrate,  1 mM PMSF) for 5 rain.  1 #1 of endoglycosidase 
H (Endo H; Boehringer Mannheim Corp., Indianapolis, IN) was 
added to half of the sample, and the other half remained untreated. 
Both treated and untreated  samples were incubated overnight at 
37~  in 5% CO2. After immunoprecipitation for TL antigen, ly- 
sates were incubated with 28-8-6S or 28-14-8S for the immunopre- 
cipitation of Kb/D  b or D b, respectively.  These samples were treated 
as described for the immunoprecipitation of TL antigen. Samples 
were analyzed  by electrophoresis  on SDS-12% polyacrylamide  gels. 
Kinetics of Arrival of Class I Molecules at the Cell Suite.  Cells 
were labeled with [3SS]methionine  for 30 rain and chased in me- 
dium containing excess methionine as described above. Before cell 
lysis, cell surface proteins were biotinylated twice for 20 rain with 
1/zg/ml sulfo-NHS-biotin  (Pierce Chemical Co., Rockford,  IL) 
in  PBS containing  Ca  2+  and  Mg  2+  (PBS*).  The reaction was 
quenched by washing the cells with PBS + containing 50 mM ly- 
sine. The ceUs were then lysed in RIPA buffer (50 mM Tris-HC1 
[pH 7.6], 150 mM NaC1, 1% Triton X-100, 0.5% deoxycholate, 
1 mM PMSF) without SDS and centrifuged to remove cellular de- 
bris. Before immunoprecipitation,  SDS was added to a final con- 
centration  of 0.1%. Lysates were serially immunoprecipitated as 
described above first for the TL antigen and then for Kb/D  b. Pro- 
tein bound to protein G beads was recovered by boiling twice in 
100 #1 of elution buffer (1% SDS, 0.2 M Tris-HC1 [pH 8.5], 5 
mM ethylene glycol-bis  (b-aminoethyl  ether)-N,N,N',N'-tetraacetic 
acid) for 2 rain and then washing in 300/zl RIPA buffer, The eluates 
and wash were pooled and incubated with 50/zl of slurry con- 
taining Streptavidin-agarose  beads (Pierce Chemical Co.) overnight 
at 4~  The beads were washed four times in RIPA buffer and 
boiled in 30/zl sample buffer. Samples were analyzed by SDS-12% 
polyacrylamide gels. 
Isolation and Purification of Soluble TL Antigen.  5 liters of  insect 
cells cotransfected with TL.s-pRM and fl2m-pRM was induced 
with 1 mM CuSO4 and incubated for 3 d. Cells were centrifuged 
at 3,000 g for 10 rain and the supernatant concentrated 20 times 
by use of  a tangential flow concentrator with a 30-kD cutoff  mem- 
brane (Filtron Technology Corp., Northborough, MA) before di- 
alysis against PBS. Isolation of the soluble TL/fl2m complex was 
done by Ni-agarose (Ni-NTA;  Qiagen,  Inc.,  Chatsworth,  CA) 
affinity chromatography. The nickel metal binds the six-histidine 
tag at the COOH terminus of the TL antigen H chain. The mate- 
rial was eluted with 100 mM imidazole and was further purified 
by fast protein  liquid chromatography  using an anion exchange 
Mono Q column (Pharmacia Inc.) in a buffer (50 mM Tris-HC1 
pH 8,  1 mM EDTA) with a salt gradient. 
Thermal Stability Assay for Soluble Molecules.  5 /zg of either 
soluble TL/flzm or soluble Kb/fl2m complex was incubated in 100 
#I of  PBS, 1% Triton X-100, for 2 h at the indicated temperatures. 
TL or K  b H chain was recovered  by absorption to 5 ml of Ni-NTA 
agarose beads. Beads were then washed with PBS, 1% Triton X- 100, 
10 mM imidazole, and TL antigen or K  b was ehited either with 
PBS, 1% Triton, 100 mM imidazole, or by boiling in SDS-PAGE 
sample buffer. The isolated material was analyzed by SDS-15% 
polyacrylamide gels and  silver staining  (Bio-Rad Laboratories, 
Richmond, CA). 
Amino  Acid Sequencing and Biochemical Analysis.  4 nmol of 
soluble TL//3zm complex purified as described above by Ni affinity 
chromatography was washed twice with a 50-mM NH,Ac buffer 
using a Centricon 10 (10 kD cutoff; Amicon, Beverly, MA) and 
concentrated to 200/zl. Bound peptides were extracted with 0.1% 
TFA for 30 rain and filtered through a Centricon-10 membrane 
as previously described (42). The extract was dried and subjected 
to peptide sequencing or laser desorption mass spectrometry. In 
addition, 100 pmol of the whole complex were directly subjected 
to Edman degradation to compare the level of amino acid signal 
from the putative TL-bound peptides versus those corresponding 
to the NH2-terminal positions of/32m and TL H chain. 
Results 
Expression of the TL Antigen is TAP lndependent.  RMA-S 
is a T  lymphoma cell line that lacks the TAP-2 subunit of 
the peptide antigen transporter (9, 10, 43). Class I molecules 
are poorly expressed on the call surface of RMA-S calls cul- 
tured at 37~  but empty molecules are expressed on the 
surface when the ceils are incubated at lower temperatures 
(44).  Expression is stabilized if peptide capable of binding 
to the class I molecule is added before incubation at 37~ 
We therefore intended to use RMA-S cells that express the 
TL antigen to assay for TL-binding peptides. A cDNA done 
encoding the TL antigen expressed under the control of the 
human fl-actin promoter was transfected into both mutant 
RMA-S and parental RMA cells.  Stable transfectants were 
incubated overnight at either 37~  or 22~  and analyzed 
by flow cytometry for surface expression of the TL antigen 
and Kb/D  b.  We were surprised to find that high levels of 
TL antigen could be equally well detected at 37~  and at 
room temperature (Fig.  1, a and b). Similar results were ob- 
22 ~  37 ~ 
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Figure 1.  High  levels  of the TL antigen  are expressed  at 37~  on RMA-S 
cells. RMA-S transfectants  were incubated at 22~  (a and c) or at 37~ 
(b and d) and analyzed  by flow cytometry  for cell surface  expression of 
the TL antigen (a and b) or Kb/Db molecules encoded by endogenous 
genes in the transfectants (c and d). The mean fluorescence  is indicated 
in the upper right corner of each panel. 
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expressing  T18  d under the control of the D a promoter as 
well as those in which TL antigen expression is driven by 
the 3-actin promoter (data not shown). In contrast, high levels 
of Kb/D  b were expressed only at 22~  (Fig.  1, c and d). 
Similar results on TL antigen expression were obtained when 
the RMA-S transfectants were analyzed in serum-free medium 
(data not  shown), indicating that  antigen processing and 
binding were not occurring in the tissue culture medium. 
RMA-S cells also were transfected with a construct en- 
coding either the L a molecule or a chimeric molecule con- 
taining the or1 and or2 regions of the L d molecule and the 
o~3, transmembrane, and cytoplasmic domains of the TL an- 
tigen from T/8  d (Ld/TL).  MAb 30-5-7,  which recognizes 
the or2 domain of L d, was used to detect cell surface expres- 
sion of molecules encoded by either construct. None of three 
anti-TL antigen mAbs that were tested reacted with the chi- 
meric class I molecule (data not shown), indicating that the 
epitope(s) recognized by these antibodies requires the or1 
and/or c~2 domain. Only low levels of L d or La/TL  were 
expressed by RMA-S transfectants incubated at 37~  the 
levels increased substantially when the cells were incubated 
at room temperature (Table 1 and data not shown). It is pos- 
sible, however, that the chimeric La/TL class I molecule is 
unable to bind 32m, and that this could result in the low 
levels of surface expression in RMA-S cells cultured at 37~ 
We consider this unlikely, because L cell transfectants that 
express  the Ld/TL chimera are recognized as effectively as 
L a transfectants by anti-L  d alloreactive T cells (28).  To fur- 
ther assess the ability of the La/TL molecule to bind 32m, 
RMA-S cell transfectants that express the Ld/TL chimeric 
molecule were incubated overnight at room temperature, and 
two peptides known to bind specifically to the L d molecule 
were then added to the transfectants before shifting the cells 
to 37~  for 3-5 h. Transfectants not incubated in the pres- 
ence of peptide rapidly lost cell surface expression of Ld/TL. 
In contrast, the addition of either one of the two La-specific 
peptides stabilized cell surface expression of the transfected 
chimeric molecule, but not of endogenous K b (Table 1). The 
level of Ld/TL expression is even higher than that in trans- 
fectants cultured at low temperature. Because there is in general 
only a minimal amount of peptide antigen binding to free 
class I H  chains, the data suggest that the La/TL chimera 
is not defective for 132m association.  Furthermore, because 
the 3-actin promoter was used for the Ld/TL and TL an- 
tigen transfectants, this result also demonstrates that escape 
to the cell surface in the absence of TAP is not likely to be 
due to the high levels of class I expression in the transf~tants. 
The TL Antigen Traffics Normally from the ER to the Golgi 
Apparatus in RMA-S Cells.  Flow cytometric analysis of the 
TL antigen on the surface of RMA-S transfectants only shows 
the steady state level of TL antigen surface expression. If the 
TL molecule had a very long half-life on the cell surface, high 
levels of the TL antigen eventually could accumulate on the 
cell surface,  even in TAP-defident cells, due to possible  es- 
cape from the Elk. To test this possibility, a series of  pulse-chase 
labeling  studies  was  carried  out  to  measure intracellular 
trafficking of the TL antigen. We first determined the rate 
at which the TL molecule reaches the Golgi apparatus by 
measuring the acquisition of Endo H  resistance.  Cells were 
pulse labeled with [3SS]methionine  as described and chased 
with cold medium for the indicated times. At each time point, 
an aliquot of cells was lysed and immunoprecipitated for the 
TL antigen or D b. Samples were then incubated in the pres- 
ence or absence of Endo H, which cleaves the mannose-rich 
carbohydrates that are modified in the Golgi apparatus. Fig. 
2 compares the acquisition of Endo H resistance by TL an- 
tigen immunoprecipitated from RMA-S (Fig. 2 a) and RMA 
(Fig.  2 b) transfectants. In both cell lines,  the transport of 
TL antigen from the Elk to the Golgi apparatus is complete 
in '~2.5-3 h, indicating that the TAP defect in RMA-S cells 
does not grossly affect the transport of the TL antigen. 3~m 
is coprecipitated with TL antigen H chain in the mutant cell 
line as well as in the normal cell line. The D b molecule ar- 
rived at the Golgi apparatus in RMA cells with similar or 
slightly more rapid kinetics than the TL antigen (data not 
shown). The difference may be attributed to the highly in- 
creased levels of intrinsic expression in the transfectants, which 
might overload the Golgi transport system, or to intrinsic 
differences in rate of transport of different class I molecules. 
In contrast to the results in RMA cells,  no detectable D b 
molecules became Endo H resistant in RMA-S cells (Fig. 3). 
TL Antigen Traffics to the Cell Surface with Kinetics Similar 
to Classical Class I Molecules.  TL antigen may traffic differ- 
ently from dassical dass I molecules and acquire peptide in 
a site other than the ER, thus resulting in the TAP-independent 
expression of the TL antigen. Classical class I molecules are 
transported to the cell surface within 1-2 h, while class II 
molecules generally require up to 8 h for transport (45). The 
additional time required for class II molecules is due in part 
to transport through endosomes. To determine if TL antigen 
traffics more like classical class I or class II molecules, we 
Table  1.  Ld-specific Peptides Stabilize  Cell Su~'ace Expression of Ld/TL  on RMA-S  Transfectants 
26~  37~  26~  -~ 37~  *  Control peptide  QLSPFPFDL  YPHFMPTNL 
Ld/TL  24  6  8  10  41  38 
K  b  22  7  8  6  7  6 
Numbers indicate mean intensity of fluorescence. 
* 26~  -~ 37~  means cells cultured overnight at 26"C and then shifted to 37~  for 3-5 h. 
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normally  from  the ER to the Golgi 
apparatus in the absence of TAE 
RMA-S (a) or control RMA (b) 
transfectants were pulse labeled 
with [3sS]methionine  and chased  in 
RPMI with excess  cold  methionine 
for various times. Cells were lysed 
at the times indicated,  and TL an- 
tigen  was immunopredpitated  from 
each sample. Half of the sample 
taken at each time point was in- 
cubated overnight  in the presence 
of Endo H (+); the other half re- 
mained  untreated  (-). Samples  were 
analyzed  by gel electrophoresis.  HC, 
heavy chain of the TL molecule. 
metabolically labeled RMA-S and KMA transfectants with 
[3SS]methionine and chased for the indicated times. Surface 
proteins were biotinylated  before cell lysis, and the TL mole- 
cule or Kb/D  b molecules were immunoprecipitated. After 
immunoprecipitation, molecules that had arrived at the cell 
surface  were  specifically reprecipitated using Streptavidin- 
agarose beads.  The results are shown in Fig. 4.  At time 0, 
no Streptavidin-agarose precipitated band corresponding ei- 
ther to the TL antigen or to classical class I molecules was 
evident on SDS-PAGE. This demonstrates that the biotiny- 
lation reagent did not leak into the cells, and therefore that 
internal proteins were not biotinylated. Low levels of TL an- 
tigen were present on the cell surface of RMA-S transfec- 
tants within 1 h, while maximal levels were expressed at 2 
and 3 h  after labeling. There was no significant difference 
in the kinetics of surface expression  for the TL antigen iso- 
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lated from normal RMA or mutant RMA-S transfectants. 
Kinetics of arrival at the cell surface similar to those for the 
TL antigen were seen when classical class I molecules were 
immunoprecipitated from RMA cells, while no detectable 
classical class I molecules reached the cell surface of RMA-S 
cells (Fig.  4). 
Soluble TL Antigen Is Resistant to Thermal Denaturation.  To 
determine if TL antigen expression is dependent upon a TAP- 
independent peptide-loading pathway, we transfected SC2 em- 
bryo cells with a TL antigen expression construct. D  melan- 
ogaster is assumed to have a much broader defect in peptide 
loading of MHC molecules than the RMA-S cells. Consis- 
tent with this assumption, it has been shown that transfected 
insect cells are deficient for both classical class I and class II 
peptide loading (46, 47). Empty class I antigens in the native 
conformation produced by fly cells are unstable at 37~  while Figure 3.  H-2D  b does not become Endo H resistant in RMA-S cells. 
RMA-S cell TL antigen transfectants were labded with [3sS]methionine 
as described in Fig. 2, and H-2D  b was immunoprecipitated  from each 
sample. Time points are indicated above the lanes. (+) indicates treatment 
with Endo H; (-) indicates that the samples remained untreated.  HC, 
heavy chain of the D b molecule. 
binding of allele-specific  peptides renders them thermostable. 
The loss of  the native conformation upon heating is associated 
with the loss of 32m. We therefore tested the thermal sta- 
bility of TL antigen produced by insect cells by measuring 
its association with 32m after incubation at various temper- 
atures; K  b molecules from insect cells were tested in parallel. 
Stable transfectants expressing a truncated form of the TL 
antigen H chain, consisting of  the ol1-~3 domains and ending 
with a six-histidine tag, and mouse/32m were established in 
order to produce soluble TL/~2m complexes. We produced 
and analyzed soluble molecules for three reasons. First, the 
purified molecules can be treated at a variety of  temperatures, 
while the insect cells are not viable for long periods above 
33~  Second, the levels of cell surface expression of class 
I molecules in/) melanogaster cells tend to be quite variable, 
even after CuSO4 induction of molecules expressed under 
the control of  the metallothionein promoter. In contrast, the 
level of  production of the soluble class I-expressing cell lines 
is ~0.5 mg/liter ofcuhure (Castafio, A. R., data not shown). 
Third, for classical class I molecules, there is no difference 
in the thermal properties of soluble versus cell surface  peptide- 
free molecules. 
To test the thermal stability, class I molecules  were incubated 
for 2 h at different temperatures, precipitated with Ni beads, 
and electrophoresed on SDS-PAGE. The class I H chain and 
~2m bands were detected by silver staining. As can be seen 
from Fig. 5 a, similar amounts of both TL antigen H chain 
and 32m are precipitated at 37~  and room temperature, in- 
dicating that the TL antigen heterodimer is stable at physio- 
logical temperatures. Consistent  with previous experiments 
(46),  the level of 32m associated with the K  b H  chain at 
37~  is much lower than that detected at room temperature 
(data not shown).  Scanning and integration analysis of the 
signal allowed quantification of the gel data for both the TL 
antigen and K  b. As shown in Fig. 5 b, which averages data 
from several different experiments,  almost  90%  of the TL 
complex remains stable, or 32m associated, at 37~  com- 
pared  with  only  15%  of Kb/32m.  From  the bar  graph 
shown in Fig. 5 b, we calculated the temperature at which 
50% of the molecule is still folded, tl/2,  to be 44~  for the 
TL  antigen,  compared  with  26~  determined for K  b in 
these and previous experiments (46). These data suggest that 
Figure 4.  TL antigen trai~cs to the cell surface 
within 2 h in both normal and TAP-mutant  cells. 
Cells were pulse labeled with [3sS]methionine  and 
chased for the indicated times as described. Sur- 
face proteins were biotinyhted  before cell lysis.  Ly- 
sates were incubated with HD168 for the immu- 
noprecipitation of TL antigen (lanes I-8) or with 
28-8-6S for the immunoprecipitation of H-2Kb/D  b 
(lanes 9-16). Samples were eluted from protein G 
beads, and Streptavidin-agarose beads were added 
to precipitate the biotinylated surface proteins. A, 
molecules immunoptxmipitated from RMA trans- 
fectants; S, molecules immunoprecipitated  from 
RMA-S transfectants. 
1438  Thymus Leukemia Antigen Expression Is TAP Independent Figure 5.  Thermal stability of 132m association with TL and K  b molecules from insect cells. (a) SDS-PAGE of soluble TL antigen after incubating 
at the indicated temperatures. The upper band of the silver-stained gel corresponds to the TL H chain and the lower band to Bzm. (b) Quantification 
of thermostability  assay. Scanning and analysis of the silver-stained gels was done with a densitometer to quantify the amount of protein in each band. 
Stability was determined  as the ratio of fJzm to TL antigen, or B2m to K b, and is expressed as a percentage of the ratio of ~2m/class I H chain at 
room temperature.  Histograms  represent the average of four experiments for the TL antigen and two for K b. 
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Figure 6.  Amino  acid  sequences  analysis. 
(a) Analysis  of the acid extract from 4 nmol 
of soluble TL from insect cells. The total 
amount detected at each cycle  of the Edman 
degradation is represented, in pmoles, for 
each amino add. Scale  represents 4% of the 
starting material. (b) Amino acid sequence 
of "~100 pmol of the TL//~rn complex. 
Total amount of residues detected at each 
cycle of the Edman degradation are repre- 
sented,  in  pmol,  versus  cycle number. 
Amino acid signals corresponding  to the 
B2m NH2 terminus,  IQKTPQI, are indi- 
cated in bold letters. The one-letter code 
followed by 2 denotes amino acid signals 
corresponding to carry over from the pre- 
vious cycle. most of the TL antigen produced by D  melanogaster cells is 
loaded with peptide or some other ligand, or that ligand- 
free molecules are thermally stable. 
TL Antigen from Insect Cells is Devoid of PeFtides.  To de- 
termine if the soluble TL molecules produced by insect cells 
contain bound peptides, four nmol of the TL/32m complex 
were acid extracted in the presence of 0.1%  TFA, and the 
low molecular weight fraction of the extract was subjected 
to peptide sequencing, as was previously done for class I mol- 
ecules (42). Only the typical contaminants glycine and serine 
were found in the first cycle, and their carryover was found 
in the succeeding seven cycles (Fig. 6 a). Their signal represents 
<(6% of the starting material. No other amino acids were 
found significantly above the detection limit of the apparatus 
(1 pmol), although the amount of protein used was in a 4,000- 
fold excess. 
To corroborate the absence of material suitable for Edman 
degradation bound to the TL H chain, 100 pmol of the purified 
TL/32m complex before acid elution were subjected to pep- 
tide sequencing. In principle, this should reveal the presence 
of three sequences in molar equivalence: 32m, TL H chain, 
and the anchor amino acids from the bound peptide. As shown 
in Fig. 6 b, only amino acids corresponding to the sequence 
of the 32m were found, with a 60% yield in the first cycle 
respective to the 100 pmol of starting material. No other amino 
acids were found above 3 pmol in the first cycles, except threo- 
nine in cycle one. These data suggest that ff peptides are bound 
to the TL antigen, they lack a dominant or anchor amino 
acid.  In  addition,  excluding the 32m  carryover from the 
previous cycle, the sum of all of the amino acids detected was 
never ~>15% of the 32m signal, suggesting that all or most 
of the molecules do not contain peptides, or that bound pep- 
tides are blocked in their NH2 terminus. Similarly, the ab- 
sence of any amino acid corresponding to the H chain of the 
TL antigen suggests that its NH2 terminus is blocked. A 
subsequent attempt to sequence the H  chain isolated from 
an SDS-PAGE  gel of purified TL antigen also failed,  sup- 
porting  this  interpretation  (data  not  shown).  The  NH2- 
terminal blocked TL H chain cannot be attributed to an ar- 
tifact caused by the D  melanogaster  expression system because 
the TL H chain isolated from mammalian cells also is blocked 
(Joyce, S.,  and M.  Chorney, personal communication). 
To detect blocked peptides that may have been bound to 
the TL antigen, acid extract from 100 pmol of the TL/32m 
complex was subjected to MALDI-mass spectrometry. No 
detectable signal of <10 kD was detected. Only a peak of 
12 kD, which most likely corresponds to a minimal amount 
of 32m  that  passed  through the Centricon-10 membrane, 
was detected. These results strongly suggest that most, if 
not all, of the soluble TL molecules produced in D. melano- 
gaster are devoid of peptide. 
Discussion 
We have demonstrated that the TL molecule is stably ex- 
pressed on the surface of mouse cells lacking TAP-2. Surface 
expression in the absence of transporter protein function results 
from normal transport to the cell surface rather than a slow 
accumulation of molecules that leak from the ER, and the 
o~1 and oe2 domains of the TL antigen apparently are neces- 
sary, although they may not be sufficient. In this respect, 
the TL molecule behaves differently from all other MHC- 
encoded class I molecules that have been studied, including 
several nonclassical  class I molecules (9,  48-50).  The Qa-1 
molecule, encoded by the T23 gene, may be a partial excep- 
tion to the TAP-dependent rule for MHC-encoded class I 
molecules. Only some of a panel of Qa-l-specific CTL clones 
required transporter function (51). Although this result sug- 
gests  that  Qa-1  expression is  partially TAP independent, 
specific mAbs for quantitation of Qa-1 surface expression are 
not available, and it is not known to what degree surface 
expression of this molecule is affected by the absence of TAP. 
In contrast to these results on MHC-encoded nonclassical 
class I molecules, class I-like CD1 molecules that are encoded 
by  genes  unlinked  to  the  MHC  are  expressed  in  TAP- 
2-deficient humans (52) and by TAP-deficient transfectants 
(TeiteU, M., and M. Kronenberg, manuscript in preparation). 
Although improperly folded classical class I molecules are 
in some cases able to reach the cell surface, they do so rela- 
tively inefficiently. We therefore consider it unlikely that the 
relatively high levels of surface TL expression in the absence 
of TAP  function  are  due  to  the  possible  conformation- 
insensitive reactivity of the antioTL antibodies. Consistent 
with this, after biosynthetic labeling, two anti-TL mAbs failed 
to immunoprecipitate TL antigen from R1E, a 32m-deficient 
mutant (53, data not shown). TL molecules could be immu- 
noprecipitated, however, from the 32m + R1.1  parent cell 
line. Thus, these two mAbs require that TL antigen be as- 
sociated with B2m for detection, and therefore they are likely 
to require the native conformation. 
Soluble TL antigen produced in D. melanogaster  cells is as- 
sociated with 32m at temperatures up to 45~  providing 
further conformation that dass I molecules in the TAP-deficient 
cells are in the native confirmation. The thermostable, soluble 
TL molecules produced by insect cells behave similarly to 
classical class I molecules that have been loaded with pep- 
tide. Several attempts to identify peptides from the soluble 
TL/32m complexes indicate that these molecules are devoid 
of detectable peptide. It is possible  that peptides bound by 
the TL antigen have a modified NH2 terminus that precludes 
sequencing by Edman degradation. However, this hypoth- 
esis is not supported by results obtained from mass spectom- 
etry analysis (data not shown). These mass spectometry data 
further suggest that nonpeptide ligands also are not present, 
although very low molecular weight ligands would not have 
been detected. In summary, there are two possible interpre- 
tations of the data concerning TL antigen expression by in- 
sect cells. The first,  which we consider most likely,  is that 
TL molecules can reach the cell surface and be secreted without 
bound peptides. The alternative possibility,  that peptides are 
present, is difficult to formally exclude. This would require 
that  some pathway be present in D  melanogaster cells for 
loading peptides into the TL molecule. In addition, to elude 
detection, the peptides would have to behave very differently 
during purification and analysis from the peptides bound to 
either class I or class II molecules. 
1440  Thymus Leukemia Antigen  Expression Is TAP Independent From a structural viewpoint, it is not obvious why peptide- 
free TL  molecules might be  stable  while classical  class  I 
molecules clearly are not.  Binding  of/32m can,  however, 
contribute to the stabilization of both empty and peptide- 
containing class I molecules. It has been reported that a number 
of mouse class I molecules can be stably expressed in human 
T2 cells (54).  Mouse class I H  chains have a higher affinity 
for heterologous human ~2m than they do for mouse/32m 
(55,  56).  In fact,  the mouse class I  H  chain/human/32m 
complexes  are  more  thermostable  than  their  class  I  H 
chain/mouse/32m  counterparts,  increasing the tl/2  of the 
complexes by "~8 ~ (46).  Therefore, a plausible explanation 
for the TAPqndependent expression of mouse class I mole- 
cules in human cells is that the high affinity for human B2m 
permits stable expression of the mouse class I H chains even 
in the absence of bound peptide. By analogy with this case, 
it is possible that the TL antigen has a higher avidity for 
mouse/32m than classical class I molecules, thus allowing 
stable  transport of empty TL molecules out of the ER in 
mouse cells. 
Although it remains to be determined whether the TL 
antigen is capable of binding peptide under any circumstances, 
its primary sequence is so similar to that of classical class I 
molecules that this seems most likely.  If this were the case, 
then the ability of the TL antigen to efficiently leave the EK 
without peptide could free it to pick up peptide in some other 
site.  Recent experiments suggest that under some circum- 
stances post-Golgi classical class I molecules might acquire 
peptides (57). It is possible that what may be a relatively minor 
pathway for peptide acquisition by K and D molecules could 
be the major pathway for the TL antigen. 
We have shown that the mouse CD1 molecule, which also 
is  expressed by  gut  enterocytes,  is  expressed  in  a  TAP- 
independent fashion similar to the TL antigen (Teitell, M., 
and M.  Kronenberg, manuscript in preparation).  It is not 
likely to be an accident that the two nonpolymorphic class 
I molecules expressed by mouse enterocytes show this char- 
acteristic and unusual behavior. Although the TAP-indepen- 
dent expression of these molecules is likely to relate to their 
specialized  immune function in the mucosae, we can only 
speculate as to what this function might be.  It is possible 
that empty class I molecules are recognized by mucosal lym- 
phocytes that express ~/~ TCRs. Recognition of MHC mol- 
ecules by "y6 T cells may in some cases not be dependent on 
bound peptides (50).  Alternatively, empty TL antigen, and 
possibly also CD1, may bind lumenal peptides by preferen- 
tially sorting to the apical surface of enterocytes, or they may 
bind lumenal-derived peptides by recycling from the surface 
to endosomes and back again. Peptide acquired in this way 
could subsequently be presented to intestinal intraepithelial 
lymphocytes or to lamina propria lymphocytes located in the 
submucosa. Soluble TL antigen produced in fly cells would 
not have the opportunity to recycle, and therefore would be 
expected to be free of peptide. 
In summary, we have shown that the TL antigen traffics 
normally and is stably expressed on the surface of cells that 
lack a functional transporter. In addition, soluble TL antigen 
expressed in/~ melanogaster cells appears  to be peptide free. 
These properties give us insight into the possible specialized 
functions of the TL antigen, and perhaps also the functions 
of other nonclassical class I molecules, in gut mucosae. 
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